# FDA 483 - Hoxworth Blood Center University of Cincinnati - September 08, 2025

Source: https://www.keypedia.com/records/483/hoxworth-blood-center-university-of-cincinnati/488f1a66-b409-43ab-aeeb-614fc7396990

> FDA 483 for Hoxworth Blood Center University of Cincinnati on September 08, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hoxworth Blood Center University of Cincinnati
- Inspection Date: 2025-09-08
- Product Type: biologics
- Office Name: FDA District Office — Cincinnati, Ohio
- Summary: An FDA inspection of Hoxworth Blood Center University of Cincinnati, a blood bank, identified two observations. The firm failed to consistently follow its written standard operating procedures regarding the logging of blood collection supplies and obtaining donor contact information for post-donation follow-up. These issues indicate a need for improved adherence to established quality management and donor registration protocols.

## Related Documents

- [483 - 2019-09-04](https://www.keypedia.com/records/483/hoxworth-blood-center-university-of-cincinnati/7258797f-d3cd-4d02-ba02-07dc300fab4e)
- [483 - 2025-09-08](https://www.keypedia.com/records/483/hoxworth-blood-center-university-of-cincinnati/861ae94d-47d3-4841-a83a-1f1b955e0a46)

## Related Officers

- [Jennifer L. Sheehan](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/hoxworth-blood-center-university-of-cincinnati/df854a82-5d7e-42da-94a6-433fc7194477

Office: https://www.keypedia.com/offices/fda-district-office-cincinnati-ohio/b4972fd9-9db9-4cc6-9a4c-0146959c9d74
